MedPath

Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study

Phase 2
Conditions
Pulmonary Emphysema
Interventions
Device: IBV Implantation
Registration Number
NCT00995852
Lead Sponsor
Heidelberg University
Brief Summary

Patients with bilateral heterogeneous pulmonary emphysema benefit to differing degrees from unilateral ELVR with complete lobe closure in comparison with incomplete bilateral treatment.

Detailed Description

Patient enrolment and data acquisition is to be carried out on a prospective basis. It is planned to enrol a total of 20 patients with bilateral heterogeneous pulmonary emphysema. All patients will undergo treatment at one study centre in Heidelberg. Patients will be considered for both unilateral and bilateral treatment with intrabronchial valves (IBV) on the basis of their emphysema distribution. Patients will be randomised to two treatment arms. 10 patients receive unilateral or bilateral treatment in each case.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • age > 40 inhomogeneous emphysema FEV1 between 20-40% DLCO between 20-40% 6MWT > 150 m
Exclusion Criteria
  • pregnant homogeneous disease FEV1 < 20%

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
bilateralIBV ImplantationTreatment arm B - incomplete bilateral treatment of in total two lobes (contralateral). The study will only use Intrabronchial Valves™
unilateralIBV ImplantationTreatment arm A - unilateral treatment with complete closure of the worst lobe of the lungs
Primary Outcome Measures
NameTimeMethod
Improvement in pulmonary function (FEV1) 6-minute walking test3 months
Secondary Outcome Measures
NameTimeMethod
Number of major complications(SAE)3 months
Evaluation of the IBV migration rate3 months
Average changes in quality of life (SGRQ)3 months
Average changes in pulmonary function (FEV1, IVC, RV, TLC, RV/TLC)3 months

Trial Locations

Locations (1)

Thoraxklinik Heidelberg

🇩🇪

Heidelberg, Germany

© Copyright 2025. All Rights Reserved by MedPath